Tuberculosis Detection Could Improve With Conversion Value Change

Share this content:
The researchers found that IFNγ values were <0.2 IU/mL among individuals with no known M tb exposure.
The researchers found that IFNγ values were <0.2 IU/mL among individuals with no known M tb exposure.

HealthDay News — A change of QuantiFERON-TB interferon (IFN)γ values from <0.2 to >0.7 IU/mL is associated with an increased incidence in the rate of tuberculosis, according to a study published in the American Journal of Respiratory and Critical Care Medicine.

Elisa Nemes, PhD, from the University of Cape Town in South Africa, and colleagues assessed sources of QuantiFERON-TB variability and identified optimal procedures. The authors analyzed distributions of IFNγ response levels in healthy adolescents, Mycobacterium tuberculosis (M tb)-unexposed controls, and pulmonary tuberculosis patients.

The researchers found that IFNγ values were <0.2 IU/mL among individuals with no known M tb exposure.

 Tuberculin skin test positivity was 15%, 53%, 66%, and 91%, respectively, among individuals with IFNγ values <0.2, 0.2 to 0.34, 0.35 to 0.7, and >0.7 IU/mL. The incidence rates of tuberculosis were 10-fold higher for individuals who had a change in QuantiFERON-TB IFNγ values from <0.2 to >0.7 IU/mL, compared to those who maintained values <0.2 IU/mL over 2 years (P = .0003). Overall, 87% of patients with active TB had IFNγ values >0.7 IU/mL.

"Implementation of optimized procedures and a more rigorous QuantiFERON-TB conversion definition, an increase from IFNγ <0.2 to >0.7 IU/mL, would allow more definitive detection of recent M tb infection and potentially improve identification of those more likely to develop disease," the authors write.

The study was partially funded by AERAS.

Reference

Nemes E, Rozot V, geldenhuys H, et al. Optimization and interpretation of serial QuantiFERON testing to measure acquisition of M tuberculosis infection [published online July 24, 2017]. Am J Respir Crit Care Med. doi: 10.1164/rccm.201704-0817OC.

You must be a registered member of Infectious Disease Advisor to post a comment.

Sign Up for Free e-newsletters